|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 17.93 USD | -0.17% |
|
+4.91% | +5.15% |
| May. 01 | Wall Street Set to Open Lower Ahead of Fed Rate Decision; Private Employment Figures Top Forecasts | MT |
| May. 01 | Transcript : TG Therapeutics, Inc., Q1 2024 Earnings Call, May 01, 2024 |
TG Therapeutics, Inc. reported earnings results for the first quarter ended March 31, 2024. For the first quarter, the company reported revenue was USD 63.47 million compared to USD 7.8 million a year ago. Net loss was USD 10.71 million compared to USD 39.23 million a year ago.
Basic loss per share from continuing operations was USD 0.07 compared to USD 0.28 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| +5.80% | 2.57B | |
| +28.47% | 49.18B | |
| +0.84% | 42.11B | |
| +50.47% | 40.37B | |
| -5.26% | 28.85B | |
| +13.78% | 26.09B | |
| -22.26% | 18.71B | |
| +7.87% | 13.26B | |
| +32.37% | 12.32B | |
| -0.45% | 11.99B |
TG THERAPEUTICS, INC. 
